Association among retinol-binding protein 4, small dense LDL cholesterol and oxidized LDL levels in dyslipidemia subjects

Clinical Biochemistry

Volumn 45, Issue 9, 2012, Pages 619-622

  Wu, Jia ^a   Shi, Yong hui ^a   Niu, Dong mei ^a   Li, Han qing ^a   Zhang, Chun ni ^a   Wang, Jun jun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Atherosclerosis; Dyslipidemias; Oxidized LDL; Retinol binding protein 4; Small dense LDL

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; RETINOL BINDING PROTEIN 4; SMALL DENSE LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS;

EID: 84862782635     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.02.022     Document Type: Article

References (39)

1. Brown M.S., Goldstein J.L. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983, 52:223-261.
2. Maggi E., Chiesa R., Melissano G., et al. LDL oxidation in patients with severe carotid atherosclerosis-a study of in vitro and in vivo oxidation markers. Arterioscler Thromb 1994, 14(12):1892-1899.
3. Holveot P., Stassen J.M., Van Cleemput J., Collen D., Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 1998, 18(1):100-107.
4. Holveot P., Donck J., Landeloos M., et al. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost 1996, 76(5):663-669.
5. Graham T.E., Yang Q., Blüher M., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006, 354(24):2552-2563.
6. Cabré A., Lázaro I., Girona J., et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 2007, 262(4):496-503.
7. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
8. Steinberger J., Moran A., Hong C.P., Jacobs D.R., Sinaiko A.R. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 2001, 138(4):469-473.
9. von Eynatten M., Lepper P.M., Liu D., et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007, 50(9):1930-1937.
10. Usui S., Ichimura M., Ikeda S., Okamoto M. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women. Clin Chim Acta 2009, 399(1-2):45-48.
11. Lee D.C., Lee J.W., Im J.A. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007, 56(3):327-331.
12. Erikstrup C., Mortensen O.H., Pedersen B.K. Retinol-binding protein 4 and insulin resistance. N Engl J Med 2006, 355(13):1393-1394.
13. Ingelssona E., Sundströmc J., Melhus H., et al. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009, 206(1):239-244.
14. Wang J.J., Gu Q.H., Li K., Zhang C.N. CETP and oxidized LDL levels increase in dyslipidemic subjects. Clin Biochem 2007, 40(13-14):995-999.
15. Chinese Medical Association Subsection of Cardiovascular Disease, Chinese Journal of Cardiology Editorial Board. Highlights of the Second National Conference on Dyslipidemia. Chin J Cardiol 2002, 30: 643-646.
16. Wang J.J., Liu X.Z., Zhuang Y.Y., Li L.Y. Correlation between susceptibility of LDL subfractions to in vitro oxidation and in vivo oxidized LDL. Clin Biochem 2000, 33(1):71-73.
17. Ito Y., Fujimara M., Ohta M., Hirane T. Development of a homogeneous assay for measurement of small, dense LDL cholesterol. Clin Chem 2011, 57(1):57-65.
18. Packard C.J., Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 1997, 17(12):3542-3556.
19. Dullaart R.P., Gansevoort R.T., Dikkeschei B.D., de Zeeuw D., de Jong P.E., Van Tol A. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993, 44(1):91-97.
20. Tatò F., Vega G.L., Tall A.R., Grundy S.M. Relation between cholesterol estertransfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995, 15(1):112-120.
21. Berneis K.K., Krauss R.M. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 2002, 43(9):1363-1379.
22. Deckelbaum R.J., Granot E., Oschry Y., Rose L., Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arteriosclerosis 1984, 4(3):225.
23. Zambon A., Hokanson J.E., Brown B.G., Brunzell J.D. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation 1999, 99(15):1959-1964.
24. Wang J.J., Zhuang Y.Y., Liu X.Z., Chen D.N. The in vivo oxidized LDL to LDL-cholesterol ratio is correlated with lipid content of LDL. Atherosclerosis 2000, 149(1):217-218.
25. Yang Q., Graham T.E., Mody N., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436(7049):356-362.
26. Gerber L.E., Erdman J.W. Retinoic acid and hypertriglyceridemia. Ann N Y Acad Sci 1981, 359:391-392.
27. Staels B. Regulation of lipid and lipoprotein metabolism by retinoids. J Am Acad Dermatol 2001, 45(5):S158-S167.
28. Vu-Dac N., Gervois P., Torra I.P., et al. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids. J Clin Invest 1998, 102(3):625-632.
29. Aalto-Setälä K., Fisher E.A., Chen X., et al. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest 1992, 90(5):1889-1900.
30. Ingelsson E., Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 2009, 32(4):733-735.
31. von Eynatten M., Humpert P.M. Retinol-binding protein 4 & atherosclerosis: risk factor or innocent bystander?. Atherosclerosis 2009, 206(1):38-39.
32. Stuck B.J., Kahn B.B. Retinol-binding protein 4 (RBP4): a biomarker for subclinical atherosclerosis?. Am J Hypertens 2009, 22(9):948-949.
33. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51(1):7-18.
34. Packard C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003, 31(Pt5):1066-1069.
35. Mallat Z., Simon T., Benessiano J., et al. Retinol binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2009, 94(1):255-260.
36. Chen C.C., Wu J.Y., Chang C.T., et al. Levels of retinol-binding 4 and uric acid in patients with type 2 diabetes mellitus. Metabolism 2009, 58(12):1812-1816.
37. Sasaki M., Otani T., Kawakami M., Ishikawa S.E. Elevation of plasma retinol-binding protein 4 and reduction of plasma adiponectin in subjects with cerebral infarction. Metabolism 2010, 59(4):527-532.
38. Bobbert T., Raila J., Schwarz F., et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213(2):549-551.
39. Solini A., Santini E., Madec S., Rossi C., Muscelli E. Retinol-binding protein-4 in women with untreated essential hypertension. Am J Hypertens 2009, 22(9):1001-1006.